We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GWAV:NASDAQGreenwave Technology Solutions, Inc. Analysis

Data as of 2026-06-30 - not real-time

$3.11

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading at $3.11, essentially at its calculated support of $3.11 and well below its 20‑day SMA of $3.43, 50‑day SMA of $3.59, and 200‑day SMA of $5.08, indicating a strong bearish bias. RSI of 38 and a bearish MACD histogram reinforce the downtrend, while the 30‑day volatility of roughly 68% signals large price swings. Volume is increasing, suggesting continued participation but not enough buying pressure to lift the price above resistance at $4.20. The company’s beta of ~0.95 implies market‑aligned risk, yet the historical max drawdown of over 90% underscores the fragility of the equity.
Fundamentals are equally concerning: revenue surged 85% to $46.7 M, but gross margin is only 14% and operating margin sits at –40%, with a net loss of $46 M (EPS –$41.25). Debt of $13.7 M dwarfs the cash balance of $0.94 M, yielding a debt‑to‑equity of 53 and a negative ROE of –68%. The stock trades at a price‑to‑book of 0.10 and price‑to‑sales of 0.06, appearing cheap on a balance‑sheet basis but unsupported by earnings. No dividend is paid, so dividend sustainability is nil. Overall, the combination of technical weakness, high volatility, and weak fundamentals makes GWAV a high‑risk play.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • price at support with bearish technicals
  • negative margins and earnings
  • high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • strong revenue growth may improve top line
  • balance sheet stress with high debt
  • potential for asset‑based valuation

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • deep discount to book value
  • possible turnaround or acquisition
  • industry consolidation opportunities

Key Metrics & Analysis

Financial Health

Revenue Growth85.30%
Profit Margin-46.28%
ROE-68.68%
ROA-21.17%
Debt/Equity52.82
P/B Ratio0.1
Op. Cash Flow$-5975441
Free Cash Flow$-660062
Industry P/E31.7

Technical Analysis

TrendBearish
RSI38.0
Support$3.11
Resistance$4.20
MA 20$3.43
MA 50$3.59
MA 200$5.08
MACDBearish
VolumeIncreasing
Fear & Greed Index89.91

Valuation

GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.95
Volatility67.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.